Literature DB >> 1845903

Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells.

J L Yates1, N Guan.   

Abstract

Some possible ways in which replication of plasmids containing the Epstein-Barr virus (EBV) plasmid maintenance origin, oriP, might be controlled were investigated. Virtually all plasmid molecules were found to replicate no more than once per cell cycle, whether replication was observed after stable introduction of the plasmids into cells by drug selection or during the first few cell divisions after introducing the DNA into cells. The presence in the cells of excess amounts of EBNA1, the only viral protein needed for oriP function, did not increase the number of oriP-replicated plasmids maintained by cells under selection. In the cell lines studied, EBNA1 and oriP seem to lack the capacity to override the cellular controls that limit DNA replication to one initiation event per DNA molecule per S phase. The multicopy status of EBV-derived, selectable plasmids appears to result from the initial uptake by cells of large numbers of plasmid molecules, the efficient maintenance of these plasmids, and the pressure of genetic selection against plasmid loss. Other unknown controls must be responsible for the amplification of EBV genomes soon after latent infection of cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1845903      PMCID: PMC240543     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

Review 1.  S phase of the cell cycle.

Authors:  R A Laskey; M P Fairman; J J Blow
Journal:  Science       Date:  1989-11-03       Impact factor: 47.728

2.  Replication of latent Epstein-Barr virus genomes in Raji cells.

Authors:  A Adams
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

3.  Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus.

Authors:  W Hammerschmidt; B Sugden
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

4.  Negative control of DNA replication in composite SV40-bovine papilloma virus plasmids.

Authors:  J M Roberts; H Weintraub
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

Review 5.  The bovine papillomavirus replicon.

Authors:  M Botchan; L Berg; J Reynolds; M Lusky
Journal:  Ciba Found Symp       Date:  1986

6.  Repression of bovine papilloma virus replication is mediated by a virally encoded trans-acting factor.

Authors:  L Berg; M Lusky; A Stenlund; M R Botchan
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

7.  Sequence analysis of Raji Epstein-Barr virus DNA.

Authors:  G Hatfull; A T Bankier; B G Barrell; P J Farrell
Journal:  Virology       Date:  1988-06       Impact factor: 3.616

8.  Bovine papilloma virus plasmids replicate randomly in mouse fibroblasts throughout S phase of the cell cycle.

Authors:  D M Gilbert; S N Cohen
Journal:  Cell       Date:  1987-07-03       Impact factor: 41.582

9.  A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus.

Authors:  B Sugden; K Marsh; J Yates
Journal:  Mol Cell Biol       Date:  1985-02       Impact factor: 4.272

10.  Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences.

Authors:  M F Law; D R Lowy; I Dvoretzky; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

View more
  139 in total

1.  Chromatin remodeling directly activates V(D)J recombination.

Authors:  S R Cherry; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

2.  An adenovirus-Epstein-Barr virus hybrid vector that stably transforms cultured cells with high efficiency.

Authors:  B T Tan; L Wu; A J Berk
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

3.  Functional analyses of the EBNA1 origin DNA binding protein of Epstein-Barr virus.

Authors:  D F Ceccarelli; L Frappier
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

4.  The Epstein-Barr virus pol catalytic subunit physically interacts with the BBLF4-BSLF1-BBLF2/3 complex.

Authors:  K Fujii; N Yokoyama; T Kiyono; K Kuzushima; M Homma; Y Nishiyama; M Fujita; T Tsurumi
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus.

Authors:  D Salamon; M Takacs; D Ujvari; J Uhlig; H Wolf; J Minarovits; H H Niller
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

6.  Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency.

Authors:  M G Davenport; J S Pagano
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

7.  Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus.

Authors:  M A Lee; M E Diamond; J L Yates
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

8.  The linking regions of EBNA1 are essential for its support of replication and transcription.

Authors:  D Mackey; B Sugden
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

9.  Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1.

Authors:  Hong Wu; Priya Kapoor; Lori Frappier
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

10.  Mre11 complex and DNA replication: linkage to E2F and sites of DNA synthesis.

Authors:  R S Maser; O K Mirzoeva; J Wells; H Olivares; B R Williams; R A Zinkel; P J Farnham; J H Petrini
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.